News

How Novo Nordisk Gave Up Its Weight-Loss Gains

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

Americans’ becoming more aware of GLP-1 drugs like Ozempic, Wegovy: Survey

The number of U.S. adults that are aware of GLP-1 drugs used for weight loss, such as Ozempic and Wegovy, has jumped ...
Study Finds14d

Popular Weight Loss Drugs Like Ozempic May Cause Major Muscle Loss Without Boosting Fitness, Study Warns

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Novo Nordisk’s Weight Loss Lesson

Furious competition in GLP-1 drugs rebuts the anti-pharma crowd.

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Wegovy maker Novo hit with investor class action over revenue forecast cut

Novo Nordisk , maker of the weight-loss drug Wegovy, has been sued in U.S. court by investors claiming the Danish ...
3 Minute Breakdowns on MSN2d

novo nordisk stock analysis: ozempic, wegovy, and market share - august 2025

Is Novo Nordisk stock a buy? An analysis of $NVO, its weight loss drugs Ozempic and Wegovy, and market share competition with ...